Reports
Rational use of medicines in Denmark
Denmark was studied in detail in a report produced by the Gesundheit Österreich GmbH / Österreichisches Bundesinstitut für Gesundheitswesen (GÖG/ÖBIG – Austrian Health Institute) which surveyed measures for promoting the rational use of medicines in the 27 EU Member States.
France’s rational use of medicines
France was studied in detail in a report produced by the Gesundheit Österreich GmbH / Österreichisches Bundesinstitut für Gesundheitswesen (GÖG/ÖBIG – Austrian Health Institute). The report surveyed measures for promoting the rational use of medicines in the 27 EU member states.
Survey on rational use of medicines in 27 EU Members States
Measures for promoting the rational use of medicines in the 27 EU Member States were surveyed in a report by the Gesundheit Österreich GmbH / Österreichisches Bundesinstitut für Gesundheitswesen (GÖG/ÖBIG – Austrian Health Institute).
Brand-name drugs show huge price increases
In a new report produced by the AARP’s (American Association of Retired Persons) Public Policy Institute it was found that average retail price increases for brand-name prescription drugs in the US have far outstripped price increases for other consumer goods and services between 2005 and 2009.
US insurers switch up to 70% of drugs
A survey carried out by the Global Healthy Living Foundation (GHLF), a non-profit patient organisation, has shown that up to 70% of prescription medications are changed by health insurers, without doctors’ approval.
US drug shortages – frustration and safety concerns
According to a survey conducted by the non-profit ISMP, there is a high level of frustration and worries about safety, concerning recent drug shortages in the US.
Fewer generic applications in the EU in 2010
Figures published by the EMA in October 2010 on centralised procedures show a reduction in the number of generic applications filed and finalised this year up to September 2010. Although this number will undoubtedly increase by the end of the year, a marked difference is already evident in comparison to 2008 and 2009, when 30 and 38 generic applications, respectively, were filed compared to only 13 filed in 2010.
Are generic medicines too expensive in Europe?
Professor Steven Simoens speaks to GaBI Online about this and other issues surrounding generics.
Pharmacists could save the NHS GBP 1 billion
More than GBP 1 billion could be saved by the National Health Service (NHS) through better use of pharmacists in improving outcomes in public health and long-term conditions, a new report claims.
Savings from generic medicines use
The Sustaining Generic Medicines Markets in Europe report (April 2006), produced by the Research Centre for Pharmaceutical Care and Pharmaco-economics and authored by Professor Steven Simoens and Mr Sandra De Coster, offers a country-by-country analysis of generics markets in Europe and discusses factors both hindering and aiding the development of generics markets.
